Atlas Capital Advisors Inc. Purchases 2,412 Shares of Fresenius Medical Care AG (NYSE:FMS)

Atlas Capital Advisors Inc. raised its position in Fresenius Medical Care AG (NYSE:FMS) by 14.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,688 shares of the company’s stock after acquiring an additional 2,412 shares during the quarter. Atlas Capital Advisors Inc.’s holdings in Fresenius Medical Care were worth $423,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. lifted its stake in Fresenius Medical Care by 11.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 22,161 shares of the company’s stock valued at $472,000 after purchasing an additional 2,233 shares during the last quarter. Glenmede Trust Co. NA acquired a new stake in shares of Fresenius Medical Care in the third quarter valued at approximately $271,000. Verition Fund Management LLC bought a new position in shares of Fresenius Medical Care during the 3rd quarter worth approximately $237,000. Quantinno Capital Management LP increased its holdings in shares of Fresenius Medical Care by 78.9% during the 3rd quarter. Quantinno Capital Management LP now owns 110,078 shares of the company’s stock worth $2,345,000 after acquiring an additional 48,554 shares during the last quarter. Finally, Virtus Investment Advisers Inc. bought a new stake in Fresenius Medical Care in the 3rd quarter valued at $226,000. Institutional investors own 8.37% of the company’s stock.

Wall Street Analysts Forecast Growth

FMS has been the subject of a number of research analyst reports. StockNews.com raised shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Truist Financial upped their price target on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th.

Fresenius Medical Care Stock Down 6.7 %

FMS stock opened at $23.94 on Friday. Fresenius Medical Care AG has a fifty-two week low of $17.93 and a fifty-two week high of $25.96. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The stock has a market capitalization of $14.05 billion, a price-to-earnings ratio of 19.79, a PEG ratio of 0.76 and a beta of 0.93. The business’s fifty day moving average price is $24.14 and its two-hundred day moving average price is $22.65.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.